![Freya Therapeutics](/media/pxbbg142/freya.png)
Headquarter
Copenhagen, Denmark
Milestones
Founded: 2020
Invested: 2023
Founders / CEO
Colleen Acosta, CEO
Vertical
Biotech
Board Participation
Paolo di Giorgio, Board Member
Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.
Freya’s drug candidates comprise full-spectrum microbiota and rationally-selected strain consortia, which have the potential to restore an optimal, non-inflammatory vaginal microbiome.